Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    No phase data available

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(2)

    Detailed Status

    Completed2

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%

    Trials by Status

    completed2100%

    Recent Activity

    0 active trials
    Showing 2 of 2
    completed

    Multivariate Analysis and Machine Learning Model Risk Prediction of Recurrent Pain After PLIF Surgery for Degenerative Lumbar Spine Disease At Long-term Follow-up

    NCT06622356
    completed

    Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

    NCT02226666

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT06622356

    Multivariate Analysis and Machine Learning Model Risk Prediction of Recurrent Pain After PLIF Surgery for Degenerative Lumbar Spine Disease At Long-term Follow-up

    Completed
    NCT02226666

    Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    2